Literature DB >> 16186534

Predicting long-term seizure outcome after resective epilepsy surgery: the multicenter study.

S S Spencer1, A T Berg, B G Vickrey, M R Sperling, C W Bazil, S Shinnar, J T Langfitt, T S Walczak, S V Pacia.   

Abstract

BACKGROUND: In a seven-center prospective observational study of resective epilepsy surgery, the authors examined probability and predictors of entering 2-year remission and the risk of subsequent relapse.
METHODS: Patients aged 12 years and over were enrolled at time of referral for epilepsy surgery, and underwent standardized evaluation, treatment, and follow-up procedures. The authors defined seizure remission as 2 years completely seizure-free after hospital discharge with or without auras, and relapse as any seizures after 2-year remission. The authors examined type of surgery, seizure, clinical and demographic variables, and localization study results with respect to prediction of seizure remission or relapse, using chi2 and proportional hazards analysis.
RESULTS: Of 396 operated patients, 339 were followed over 2 years, and 223 (66%) experienced 2-year remission, not significantly different between medial temporal (68%) and neocortical (50%) resections. In multivariable models, only absence of generalized tonic-clonic seizures and presence of hippocampal atrophy were significantly and independently associated with remission, and only in the medial temporal resection group. Fifty-five patients relapsed after 2-year remission, again not significantly different between medial temporal (25%) and neocortical (19%) resections. Only delay to remission predicted relapse, and only in medial temporal patients.
CONCLUSION: Hippocampal atrophy and a history of absence of generalized tonic clonic seizures were the sole predictors of 2-year remission, and only for medial temporal resections.

Entities:  

Mesh:

Year:  2005        PMID: 16186534     DOI: 10.1212/01.wnl.0000176055.45774.71

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  67 in total

1.  Anterior temporal lobectomy - how safe is it?

Authors:  Bruce Fisch
Journal:  Epilepsy Curr       Date:  2011-11       Impact factor: 7.500

2.  What is intractable epilepsy, and when (if ever) does it remit with medical treatment?

Authors:  Carl W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

3.  Association of Seizure Spread With Surgical Failure in Epilepsy.

Authors:  John P Andrews; Abhijeet Gummadavelli; Pue Farooque; Jennifer Bonito; Christopher Arencibia; Hal Blumenfeld; Dennis D Spencer
Journal:  JAMA Neurol       Date:  2019-04-01       Impact factor: 18.302

4.  Results of epilepsy surgery: still so much to learn.

Authors:  Donna C Bergen
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

5.  Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. epilepsy center neurologists.

Authors:  Anne T Berg; John T Langfitt; Susan S Spencer; Barbara G Vickrey
Journal:  Epilepsy Behav       Date:  2007-01-23       Impact factor: 2.937

6.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

Review 7.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

8.  Presurgical evaluations of patients with intractable epilepsy.

Authors:  R P Lesser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

9.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 10.  Prognosis of intractable epilepsy: is long-term seizure freedom possible with medical management?

Authors:  Heidi Munger Clary; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.